| Literature DB >> 31667040 |
Shoaib Un Nisa1, Altaf A Shaikh2, Raj Kumar3.
Abstract
Introduction Pregnancy-related hypertensive disorders are a significant cause of adverse maternal and fetal outcomes, especially in developing areas of the world. Preeclampsia and eclampsia are the most significant causes of maternal and perinatal morbidity and mortality. Methods We conducted a prospective observational study in the Obstetrics and Gynaecology Department of Ghulam Muhammad Meher Medical College and Hospital. One hundred twelve (n=112) women with pregnancy-related hypertensive disorders admitted for delivery were included in the study. Results The major pregnancy-related hypertensive disorder was eclampsia (n=48; 43.24%) and preeclampsia (n=28; 25.23%). Among the women who developed one or more complications during or after delivery, postpartum hemorrhage (PPH) was the most frequent (n=31; 27.6%). Conclusions Pregnancy-related hypertensive disorders are common and adversely impact maternal and fetal outcomes. Efforts should be made at both the community and hospital levels to increase awareness regarding hypertensive disorder of pregnancy and reduce its associated morbidity and mortality.Entities:
Keywords: eclampsia; fetal complication; hypertensive disorder of pregnancy; maternal complications
Year: 2019 PMID: 31667040 PMCID: PMC6816637 DOI: 10.7759/cureus.5507
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Frequencies of hypertensive disorders
HELLP, hemolysis, elevated liver enzymes, and low platelets.
| Hypertensive Disorder | Frequency (%) |
| Pregnancy-induced hypertension | 26 (23.2%) |
| Preeclampsia | 28 (25.0%) |
| Eclampsia | 48 (42.8%) |
| Chronic hypertension | 5 (4.5%) |
| Chronic hypertension superimposed | 3 (2.7%) |
| HELLP | 2 (1.8%) |
| Total | 112 (100%) |
Trends of maternal complications
ARDS, acute respiratory distress syndrome; ARF, acute renal failure; CVA, cerebrovascular accident; DIC, disseminated intravascular coagulation; HELLP, hemolysis elevated liver enzymes low platelets; HTN, hypertension; P. edema, pulmonary edema; PIH, pregnancy-induced hypertension; PPH, postpartum hemorrhage; PRES, posterior reversible encephalopathy syndrome.
| Pregnancy-related HTN disorders (N=112) | Maternal Complications | ||||||||
| Placental abruption | DIC | PPH | ARF | ARDS | PRES | P. edema | CVA | No complication | |
| PIH (n=26; 23.2%) | 9 (47.3%) | 0 | 9 (29%) | 0 | 0 | 0 | 2 (28.5%) | 0 | 6 (15.8%) |
| Preeclampsia (n=28; 25%) | 6 (31.6%) | 2 (40%) | 9 (29%) | 2 (28.5%) | 2 (50%) | 0 | 1 (14.3%) | 0 | 6 (15.8%) |
| Eclampsia (n=48; 42.8%) | 3 (15.8%) | 0 | 11 (35.5%) | 3 (42.8%) | 1 (25%) | 2 (100%) | 4 (57.2%) | 3 (100%) | 21 (55.3%) |
| HELLP (n=2; 1.8%) | 0 | 2 (40%) | 0 | 1 (14.3%) | 1 (25%) | 0 | 0 | 0 | 0 (%) |
| Chronic HTN (n=5; 4.5%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 (13.2%) |
| Chronic HTN superimposed (n=3; 2.7%) | 1 (5.2%) | 1 (20%) | 2 (6.5%) | 1 (14.3%) | 0 | 0 | 0 | 0 | 0 |
| Total (N=112; 100%) | 19 (100%) | 5 (100%) | 31 (100%) | 7 (100%) | 4 (100%) | 2 (100%) | 7 (100%) | 3 (100%) | 38 (100%) |
Trends of neonatal complications
HELLP, hemolysis elevated liver enzymes low platelets; HTN, hypertension; IUD, intrauterine death; IUGR, intrauterine growth restriction; LBW, low birth weight; NND, neonatal death; PIH, pregnancy-induced hypertension; RDS, respiratory distress syndrome.
| Pregnancy-related HTN disorders (N=112) | Neonatal Complications | ||||||||
| IUGR | Preterm | RDS | Meconium aspiration | IUD | Stillbirth | LBW | NND | No complication | |
| PIH (n=26; 23.2%) | 1 (10%) | 0 | 1 (20%) | 4 (28.5%) | 3 (27.3%) | 0 | 3 (30%) | 2 (100%) | 12 (27.3%) |
| Preeclampsia (n=28; 25%) | 1 (10%) | 3 (25%) | 3 (60%) | 3 (21.4%) | 2 (18.2%) | 0 | 5 (50%) | 0 | 11 (25%) |
| Eclampsia (n=48; 42.8%) | 8 (80%) | 8 (66.7%) | 1 (20%) | 7 (50%) | 5 (45.5%) | 4 (100%) | 2 (20%) | 0 | 13 (29.5%) |
| HELLP (n=2; 1.7%) | 0 | 1 (8.3%) | 0 | 0 | 1 (9 %) | 0 | 0 | 0 | 0 |
| Chronic HTN (n=5; 4.5%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 (11.4%) |
| Chronic HTN superimposed (n=3; 2.7%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 (6.8%) |
| Total (N=112; 100%) | 10 (100%) | 12 (100%) | 5 (100%) | 14 (100%) | 11 (100%) | 4 (100%) | 10 (100%) | 2 (100%) | 44 (100%) |